About this event

340B Coalition Summer Conference 2026

Date and Venue

The 340B Coalition Summer Conference 2026 will take place from July 10 to July 14, 2026, at the Marriott Marquis in Washington, D.C., USA.

Event Type

This is a high-profile conference focusing on the 340B Drug Pricing Program, healthcare policy, pharmaceuticals, and health services administration.

Estimated Attendance

The conference is expected to attract over 1,500 attendees, including healthcare providers, pharmaceutical companies, and government officials.

Who Attends: Buyers / Attendees

The conference is attended by a diverse group of stakeholders in the healthcare industry, including:

• Healthcare providers such as hospitals, community health centers, and clinics
• Pharmaceutical manufacturers interested in drug pricing policies
• Government officials involved in healthcare policy and regulation
• Advocacy organizations focusing on patient care and access to medication
• Consultants and service providers specializing in healthcare compliance and financial management

Location + Attendee Geographic Origin

The event will be held at the Marriott Marquis in Washington, D.C., USA. Attendees are expected to come from across the United States, with a significant number of international participants from the pharmaceutical industry and global health organizations.

Audience Reach

The conference has a national reach, with a strong emphasis on policy discussions relevant to the US healthcare system. However, it also attracts a global audience due to the international implications of drug pricing and health policy.

Sample Buyer Company Names + Websites

The following are sample companies that represent potential buyers at the conference:

• Pfizer Inc. - pfizer.com
• Johnson & Johnson - jnj.com
• Gilead Sciences - gilead.com
• CVS Health - cvshealth.com
• Walgreens Boots Alliance - walgreensbootsalliance.com

Job Profiles, Industries & Event Type

The conference is ideal for professionals in the following job profiles and industries:

• Pharmaceutical Policy Advisors
• Healthcare Compliance Officers
• Hospital Administrators
• Pharmacy Directors
• Government Affairs Specialists
• Health Services Researchers

Key Focus Areas & Buyer Engagement

Key focus areas of the conference include:

• Updates and changes in the 340B Drug Pricing Program
• Strategies for compliance and audit readiness
• Collaborative models for improving patient access to affordable medications
• Impact of healthcare policies on drug pricing and reimbursement
• Innovations in healthcare delivery systems

Buyer engagement is enhanced through interactive sessions, panel discussions, and networking events tailored to connect stakeholders with shared interests.

Client-Product Fit Note

To provide a tailored list of potential buyers, please share your client's website. This will allow for a precise match of buyers based on your client's specific product offerings and target audience.

Industry Recommendation

Based on the industry list provided, the following industries are most relevant for this conference:

• Pharmaceuticals
• Hospital & Health Care
• Government Administration
• Insurance
• Health, Wellness & Fitness
  

  340B Coalition Summer Conference 2026

  Buyer / Attendee Profile Sampling Report

  About the Event

  Field	Details
  Official event name	30th Annual 340B Coalition Summer Conference / 340B Coalition Summer Conference 2026
  Organizer / coalition context	340B Coalition / 340B Health conference ecosystem for 340B Drug Pricing Program stakeholders
  Dates	July 13-15, 2026
  Related pre-event education	340B University is listed for July 12, 2026 in National Harbor, MD
  Venue	Gaylord National Hotel & Convention Center
  City	National Harbor
  State / Region	Maryland / Washington, D.C. Capital Region
  Country	United States
  Event category from approved list	Medical & Pharma
  Event type	In-person healthcare policy, pharmacy compliance, 340B operations, covered-entity education, exhibitor and stakeholder networking conference
  Audience reach	National with selective global/pharma-policy exposure
  Estimated attendance / footfall	Official pages describe the event as the premier/largest 340B stakeholder gathering. Public third-party projections range from 1,500+ to 5,000, so use 1,500-5,000 as an estimated planning range, not a guaranteed attendee count.
  Primary attendee sectors	Covered entities, hospitals, health systems, pharmacies, pharmacy service companies, drug manufacturers, consultants, government agencies, legal/policy groups and 340B technology vendors

  1. Who Attends - Buyers / Attendees

  ·          Covered-entity leaders from hospitals, DSH systems, children’s hospitals, cancer hospitals, critical access hospitals, Ryan White/HIV clinics, FQHCs and other eligible healthcare providers.

  ·          Pharmacy executives, 340B program managers, compliance leaders, revenue integrity teams and supply-chain/procurement stakeholders who evaluate 340B tools and advisory support.

  ·          Contract pharmacy, specialty pharmacy, PBM, drug-distribution and pharmacy service company contacts looking for partnerships and program-operational visibility.

  ·          Drug manufacturer, policy, legal, government affairs and market-access professionals monitoring 340B restrictions, compliance requirements, rebate models and stakeholder advocacy.

  ·          Government, association and public-policy attendees connected to HRSA/OPA oversight, Medicaid duplicate-discount questions, safety-net access and legislative developments.

  2. Location + Attendee Geographic Origin

  Geography Item	Buyer-list implication
  Show location	Gaylord National Hotel & Convention Center, 201 Waterfront Street, National Harbor, Maryland, USA
  Likely strongest origin	United States: hospital/health-system, covered-entity, pharmacy and policy professionals from all major U.S. regions
  Regional pull	Washington, D.C. Capital Region, Maryland, Virginia, Pennsylvania, New Jersey and Mid-Atlantic healthcare policy markets
  Secondary origin	National pharma manufacturers, consulting firms, software vendors, specialty pharmacy companies and legal/policy groups
  Audience reach classification	National
  List-building implication	Build around U.S. 340B decision makers first. Prioritize health systems and covered entities, then add 340B vendors, specialty pharmacy, pharma access, compliance, legal and policy influencers.

  3. Audience Reach - Local / National / Global

  Reach type	Assessment
  Local	Moderate: National Harbor / D.C. region brings policy stakeholders, associations, consultants and local healthcare organizations.
  National	Very strong: 340B is a U.S. federal drug-pricing program, so the buyer universe is U.S.-heavy and compliance-driven.
  Global	Limited but present: multinational pharma, policy observers, market-access teams and healthcare technology vendors may participate because 340B affects U.S. pharmaceutical channel economics.

  4. Sample Buyer Company Names + Websites

  Note: These are recommended buyer-style target accounts to sample from Apollo.io, not a confirmed attendee list. Use them for sample outreach to show the client the type of decision makers you can source.

  Company	Website	Best-fit buyer angle	Titles to target
  Kaiser Permanente	https://www.kaiserpermanente.org	Large covered entity / health-system pharmacy operations	Director 340B Program; VP Pharmacy Services; Revenue Integrity Director
  CommonSpirit Health	https://www.commonspirit.org	National health system with pharmacy, compliance and safety-net operations	340B Program Director; Chief Pharmacy Officer; Director Pharmacy Compliance
  Bon Secours Mercy Health	https://www.bsmhealth.org	Large nonprofit health system and covered-entity buyer profile	Director 340B Compliance; VP Pharmacy; System Director Revenue Integrity
  Ochsner Health	https://www.ochsner.org	Health system / pharmacy operations / medication access	340B Manager; Director Pharmacy Business Services; Medication Access Director
  Community Health Systems	https://www.chs.net	Hospital operator with pharmacy and revenue-cycle needs	Director Pharmacy Operations; Revenue Cycle VP; Compliance Director
  CVS Health	https://www.cvshealth.com	Contract pharmacy, specialty pharmacy and PBM ecosystem	Director 340B Strategy; Specialty Pharmacy Partnerships; Market Access Director
  Walgreens	https://www.walgreens.com	Retail/contract pharmacy and specialty pharmacy partnership angle	Director 340B Solutions; Pharmacy Partnerships; Specialty Pharmacy Director
  Cencora	https://www.cencora.com	Pharmaceutical distribution, manufacturer services and channel strategy	Director 340B Services; VP Market Access; Manufacturer Solutions Lead
  McKesson	https://www.mckesson.com	Distribution, health-system pharmacy services and 340B consulting content	VP Pharmacy Advisory; Director 340B Solutions; Health System Account Director
  Apexus	https://www.apexus.com	340B Prime Vendor Program and education ecosystem	Director 340B Education; Program Manager; Stakeholder Engagement Lead
  Verity Solutions	https://www.verity-solutions.com	340B administration software and compliance services	VP Sales; Director Client Success; 340B Solutions Consultant
  SpendMend	https://www.spendmend.com	Healthcare spend/revenue recovery and pharmacy compliance solutions	Director 340B Audit; VP Pharmacy Solutions; Client Partner
  Visante	https://www.visante.com	Pharmacy consulting and 340B advisory services	Senior Consultant 340B; Pharmacy Revenue Cycle Principal; Client Partner
  FQHC Associates	https://www.fqhc.org	Community health center consulting and covered-entity operations	Principal Consultant; 340B Consultant; Compliance Advisor

  5. Job Profiles, Industries & Event Type

  Target job profile	Why relevant
  Chief Pharmacy Officer / VP Pharmacy	Budget owner for pharmacy operations, contract pharmacy strategy, specialty pharmacy, compliance platforms and consulting services.
  Director / Manager, 340B Program	Most direct buyer for 340B software, audit support, policy education, contract-pharmacy optimization and compliance workflows.
  Revenue Integrity / Revenue Cycle Director	Key for savings capture, claims review, duplicate-discount risk, audit readiness and program-value reporting.
  Compliance Officer / Legal Counsel	Important for HRSA audits, manufacturer restrictions, policy interpretation, contract pharmacy rules and risk management.
  Specialty Pharmacy / Ambulatory Pharmacy Leader	Influences medication access, specialty drug management, patient assistance and operational technology decisions.
  Government Affairs / Public Policy Director	Tracks legislation, advocacy, manufacturer restrictions, Medicaid rules and program reputation.
  Market Access / Trade Relations Leader	Relevant on manufacturer and pharma-services side for 340B policy and channel strategy.
  Consultant / Client Partner / Account Executive	Vendor-side buyer or partner for sponsorship, lead generation, exhibitor intelligence and attendee-list usage.

  6. Key Focus Areas & Buyer Engagement

  Focus Area	Buyer Engagement Angle
  340B compliance and audit readiness	High-value buyer pain point for covered entities and health systems; vendors can pitch software, consulting and managed-service support.
  Contract pharmacy restrictions	Core discussion area because manufacturer restrictions and access limitations create operational and financial pressure.
  Medicaid duplicate discounts	Important for state Medicaid, covered entities, pharmacies and compliance teams managing rebate/claim risk.
  Policy and advocacy	D.C.-region setting strengthens appeal for government affairs, associations, legal counsel and policy influencers.
  Pharmacy operations and revenue capture	Health systems seek workflow efficiency, savings protection, claim monitoring and medication-access program performance.
  Exhibitor / sponsor networking	Good list-conversion environment because service providers, drug companies, consultants and technology vendors attend to meet 340B decision makers.

  7. Estimated Attendance / Footfall

  Attendance item	Assessment
  Official positioning	Premier event for all 340B stakeholders; official 340B Health pages describe the conference as a major/largest gathering for the 340B community.
  Planning estimate	Use 1,500-5,000 as a cautious external planning range. Vendelux projects 1,500; 10times displays 5,000. Treat both as third-party estimates, not official guaranteed footfall.
  Best interpretation	For buyer sampling, consider it a high-value national niche conference rather than a mass healthcare expo. Quality of audience is more important than raw volume.

  8. Apollo Industry Suggestions

  Apollo industry	Use in list-building
  Hospital & Health Care	Primary match for hospitals, health systems, covered entities and medication-access teams.
  Pharmaceuticals	Drug manufacturers, market access, trade relations and pharma policy stakeholders.
  Medical Practice	Clinics and eligible healthcare provider groups, including community health and specialty-care organizations.
  Government Administration	Agencies and public-sector healthcare/policy stakeholders connected to 340B oversight.
  Public Policy	Advocacy, associations and policy groups focused on drug pricing and safety-net care.
  Legal Services	Healthcare law firms and compliance counsel involved in 340B disputes and interpretation.
  Information Technology & Services	340B software, compliance platforms, analytics and claims-monitoring vendors.
  Management Consulting	Pharmacy consulting, revenue integrity, compliance advisory and health-system optimization firms.
  Nonprofit Organization Management	Associations, safety-net organizations, grantee networks and healthcare coalitions.
  Retail	Retail/contract pharmacy chains and specialty pharmacy networks.
  Insurance	Payer/PBM-adjacent organizations and health-plan policy stakeholders.

  9. Best Buyer Segments to Prioritize

  Priority segment	Why target
  Tier 1 - Covered entities / health systems	Best match for direct 340B buyers: program directors, pharmacy executives, compliance and revenue integrity leaders.
  Tier 2 - 340B software and compliance vendors	Strong list buyers because they sponsor/exhibit, sell to attendees and need precise account/title targeting.
  Tier 3 - Contract pharmacy / specialty pharmacy	Relevant for partnership, pharmacy access, dispensing networks and medication-access operations.
  Tier 4 - Pharma manufacturers / market access	Important for policy monitoring, channel strategy, contract pharmacy restrictions and stakeholder intelligence.
  Tier 5 - Legal, policy and consulting firms	Useful for sponsorship, thought leadership, client acquisition and account intelligence around 340B change.

  10. Client Product Review Requirement

  ·          Before finalizing the buyer list, ask the client for their website and product/service description.

  ·          Review whether the client sells to covered entities, pharmacies, health systems, manufacturers, consultants, legal/policy teams or software/service providers.

  ·          Then rank buyers by program fit: 340B authority, budget control, compliance pain, pharmacy operations relevance, geography and likely conference participation.

  ·          Suggested client question: Please share your client website and product/service, so I can recommend the best 340B buyer categories and target job titles for this event.

  11. Recommended Apollo Search Filters

  Filter	Recommended setup
  Geography	United States first. For regional emphasis, prioritize Maryland, Washington DC, Virginia, Pennsylvania, New York/New Jersey, then national health-system hubs.
  Company type	Hospitals, health systems, FQHCs, specialty pharmacies, contract pharmacies, 340B software vendors, healthcare consulting, pharma manufacturers, legal/policy groups.
  Company size	Covered entities: 200-10,000+ employees. Vendors/consultants: 11-1,000+ employees depending on niche.
  Departments	Pharmacy, Compliance, Revenue Cycle, Legal, Government Affairs, Market Access, Partnerships, Sales, Client Success.
  Seniority	Manager, Director, VP, Head, Principal, Partner, Chief, Founder for vendor/consultant organizations.
  Keywords	340B, contract pharmacy, pharmacy compliance, revenue integrity, medication access, specialty pharmacy, HRSA, covered entity, Medicaid, duplicate discount.
  Exclude when needed	General wellness providers, unrelated hospital departments, consumer retail pharmacy roles without 340B, pharma R&D roles unless client specifically requests pharma manufacturers.

  Source Notes

  Source	What was used
  Official event site	Confirms July 13-15, 2026, National Harbor/Capital Region positioning and that the event serves covered entities, pharmacies, service providers, drug companies, government officials and other 340B stakeholders.
  340B Health event listing	Confirms Gaylord National Hotel & Convention Center, National Harbor, MD and the designed audience: providers, pharmacies, pharmacy service companies, manufacturers, government agencies and related entities.
  340B Coalition events page	Confirms July 13-15, 2026 and Washington, D.C. Capital Region.
  Apexus / 340B Prime Vendor Program calendar	Confirms 340B University on July 12, 2026 and 340B Coalition Summer Conference on July 13-15, 2026 in National Harbor, MD.
  Third-party attendance indicators	Vendelux projects 1,500; 10times displays 5,000. These are used only as external planning indicators, not official figures.